Back to News
Market Impact: 0.2
Globus Medical Secures CE Mark For Excelsius3D Imaging System In Europe
Source: Nasdaq
Healthcare & BiotechRegulation & LegislationProduct LaunchesCompany Fundamentals
Globus Medical said its Excelsius3D intelligent 3-in-1 imaging system received CE Mark approval, enabling commercial sales in the EU and the UK. The approval removes a key regulatory hurdle and supports potential expansion of revenue opportunities in Europe.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
GMED0.55
More News
- Indonesian stocks plunge to six-year low as MSCI downgrade fears mount
- China's CXMT sees shares drop over 6% as investors look past chipmaker's profit turnaround
- Australia’s Cleanaway agrees to $6.5 bln EQT buyout bid; shares surge
- India’s Finance Minister blames easy exits and excess liquidity for equity market's underperformance
- Zoom and big financial firms add ‘Proof of Human’ badges from Sam Altman’s World to stop fraud and deep fakes
- Daiichi Life Offers to Buy Remainder of Australia’s Challenger